Aliases & Classifications for Urethral Obstruction

About this section

Aliases & Descriptions for Urethral Obstruction:

Name: Urethral Obstruction 10 12 65 36
 
Obstruction of Urethra 10


External Ids:

Disease Ontology10 DOID:12577
MeSH36 D014524
SNOMED-CT59 95588004
NCIt42 C79804

Summaries for Urethral Obstruction

About this section
MalaCards based summary: Urethral Obstruction, also known as obstruction of urethra, is related to urethritis and prostatitis. An important gene associated with Urethral Obstruction is UBR1 (Ubiquitin Protein Ligase E3 Component N-Recognin 1), and among its related pathways is Cardiac Progenitor Differentiation. Affiliated tissues include prostate, kidney and spinal cord.

Related Diseases for Urethral Obstruction

About this section

Diseases related to Urethral Obstruction via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 47)
idRelated DiseaseScoreTop Affiliating Genes
1urethritis11.3
2prostatitis10.7
3urethral obstruction sequence10.6
4cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction10.5
5prune belly syndrome10.3
6hydronephrosis10.3
7cystitis10.3
8pyelonephritis10.3
9vaginitis10.3
10vesicoureteral reflux10.2
11hypospadias10.2
12renal fibrosis10.2
13bladder diverticulum10.2
14cystic kidney10.2
15prostatic hypertrophy10.2
16anterior urethral valve10.2
17urinary tract papillary transitional cell benign neoplasm10.1CHRM3, KLK3
18muscle hypertrophy10.0
19bacteremia10.0
20johanson-blizzard syndrome10.0
21spinal cord injury10.0
22polydactyly10.0
23gastroschisis10.0
24bacteriuria10.0
25anuria10.0
26neuronitis10.0
27imperforate anus10.0
28esophageal atresia10.0
29lymphosarcoma10.0
30cystic lymphangioma10.0
31ureterocele10.0
32cervicitis10.0
33esophagitis10.0
34lymphangioma10.0
35transitional cell carcinoma10.0
36posterior urethral valves10.0
37tracheoesophageal fistula10.0
38hyperammonemia10.0
39congenital hydronephrosis10.0
40renal dysplasia10.0
41benign pericardial teratoma10.0CHRM3, KLK3
42acute disseminated encephalomyelitis9.9CHRM3, KLK3
43bone fracture9.9CHRM3, KLK3, NRG1
44secondary vitreoretinal degeneration9.9CHRM3, ECI1, KLK3
45uterine corpus epithelioid leiomyoma9.9CHRM3, KLK3, SIRPA
46urethral urothelial papilloma9.3CHRM3, FAT4, KLHL24, KLK3, SIRPA
47urethral stricture8.5CHRM3, ECI1, FAT4, KLHL24, KLK3, NRG1

Graphical network of the top 20 diseases related to Urethral Obstruction:



Diseases related to urethral obstruction

Symptoms for Urethral Obstruction

About this section

Drugs & Therapeutics for Urethral Obstruction

About this section

Drugs for Urethral Obstruction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 28)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Tamsulosinapproved, investigationalPhase 4, Phase 2145106133-20-4129211
Synonyms:
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
106133-20-4
5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide
5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide
AC1L2V76
BIDD:GT0261
C07124
C20H28N2O5S
CHEBI:9398
CHEMBL836
CID129211
D08560
DB00706
FT-0082894
Flomax
Flomax (TN)
Flowmax
 
HMS2090P15
Harnal
LS-31578
MolPort-003-850-388
NCGC00167442-01
STK626950
TAMSULOSIN
Tamsolusin
Tamsulon
Tamsulon (TN)
Tamsulosin
Tamsulosin (INN)
Tamsulosin Hydrochloride
Tamsulosin [INN:BAN]
Tamsulosina
Tamsulosina [INN-Spanish]
Tamsulosine
Tamsulosine [INN-French]
Tamsulosinum
Tamsulosinum [INN-Latin]
UNII-G3P28OML5I
YM-617
2
Bupivacaineapproved, investigationalPhase 4, Phase 1, Phase 28532180-92-92474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Hydrochloride
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
DepoBupivacaine
 
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
Exparel
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Racemic bupivacaine
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Vivacaine
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
3
SilodosinapprovedPhase 422160970-54-75312125
Synonyms:
KAD 3213
 
KMD 3213
Rapaflo
Urief
4
DoxazosinapprovedPhase 45474191-85-83157
Synonyms:
1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[4-(1,4-benzodioxan-2-yl)carpiperazin-1-yl)]-6,7-dimethoxyquinazoline mesylate
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine
2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine
2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine
74191-85-8
77883-43-3 (mesylate)
AC-11062
AC1L1FAT
AC1Q470P
AC1Q4EXN
AKOS001681453
BPBio1_000963
BRD-A13188892-066-03-3
BSPBio_000875
C06970
C23H25N5O5
CHEBI:4708
CHEMBL707
CID3157
CPD000097306
Cardura
Cardura XL
Cardura XL (TN)
Cardura-1
Cardura-2
Cardura-4
ChemDiv2_005017
D07874
D9815_SIGMA
DB00590
 
Doxazosin
Doxazosin (INN)
Doxazosin Mesylate
Doxazosin [INN:BAN]
Doxazosin mesilate
Doxazosin mesylate
Doxazosina
Doxazosina [Spanish]
Doxazosine
Doxazosine [French]
Doxazosinum
Doxazosinum [Latin]
HMS1383E01
HMS2090C20
I06-1346
IDI1_003732
L000738
LS-110228
Lopac0_000474
MolPort-001-684-491
NCGC00018158-06
NCGC00089775-02
Normothen
Oprea1_259518
Prestwick0_000858
Prestwick1_000858
Prestwick2_000858
Prestwick3_000858
SAM002589981
SPBio_002796
UK 33274
UK-33274
UNII-NW1291F1W8
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone
doxazosin
5
Tolterodineapproved, investigationalPhase 487124937-51-560774, 443879
Synonyms:
(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol
(+)-Tolterodine
124937-51-5
2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol
2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol
2-{(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl}-4-methylphenol
AC-3472
AC1L9FDR
BIDD:GT0318
CHEBI:9622
CHEMBL1382
CID443879
Detrol
Detrol LA
Detrol La
FT-0082150
FT-0082998
Jsp001637
 
Kabi-2234
LS-187278
MLS001195620
MLS001304745
MolPort-002-885-868
MolPort-005-934-224
NCGC00159519-02
SMR000596518
Tolterodina
Tolterodina [INN-Spanish]
Tolterodine
Tolterodine L-Tartrate
Tolterodine Tartrate
Tolterodine [INN]
Tolterodine extended release capsules
Tolterodinum
Tolterodinum [INN-Latin]
Tolterondine Tartrate
tolterodine
tolterodine extended release capsules
6
Alfuzosinapproved, investigationalPhase 45081403-80-72092
Synonyms:
(±)-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide
128707-53-9
81403-68-1 (hydrochloride)
81403-80-7
86163-78-2
AB00514667
AC1L1CWF
Alfusosine
Alfuzosin
Alfuzosin (INN)
Alfuzosin Hydrochloride
Alfuzosin [INN:BAN]
Alfuzosina
Alfuzosina [Spanish]
Alfuzosine
Alfuzosine [French]
Alfuzosinum
Alfuzosinum [Latin]
BPBio1_000357
BRD-A09056319-001-02-2
BRD-A09056319-003-03-6
BSPBio_000323
BSPBio_002646
Bio-0003
C19H27N5O4
CHEBI:51141
CHEMBL709
CID2092
CPD000466340
D07124
DB00346
HMS1922P11
HMS2051I10
HMS2093O06
HSDB 7290
KBio3_001866
 
KBioGR_001616
L001317
LS-70106
MLS000759449
MLS001424027
MolPort-003-666-623
N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide
N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide
N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide
N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide
NCGC00095152-01
NCGC00095152-02
NCGC00095152-03
NCGC00095152-04
NCGC00095152-05
Prestwick0_000322
Prestwick1_000322
Prestwick2_000322
Prestwick3_000322
SAM001246638
SL 77-499
SL 77499
SMR000466340
SPBio_000429
SPBio_002244
SPECTRUM1505263
STK643675
Spectrum2_000505
Spectrum3_001063
Spectrum4_001208
Spectrum5_000817
UNII-90347YTW5F
Uroxatral
Xatral
Xatral (TN)
alfuzosin
alphuzosine
7
RopivacaineapprovedPhase 4, Phase 359084057-95-471273, 175805
Synonyms:
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(S)-(−)-1-propyl-2',6'-pipecoloxylidide
(S)-ropivacaine
84057-95-4
98717-15-8
AC1L41QM
AC1L41QN
BIDD:GT0203
C07532
C17H26N2O.HCl
CHEBI:8890
CHEMBL1077896
CID175804
CID175805
CPD000469137
D08490
I14-176
L-N-n-propylpipecolic acid-2,6-xylidide
LS-113954
 
MLS001401363
MolPort-003-983-292
NCGC00164597-01
Naropin
Naropin (TN)
ROPIVACAINE HCl
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine Hydrochloride
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
SAM001246524
SMR000469137
ST51051452
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
8
FesoterodineapprovedPhase 459286930-03-86918558
Synonyms:
FESO
 
Fesoterodine
Fesoterodine Fumarate
Toviaz
9Phase 4
10
Tramadolapproved, investigationalPhase 319527203-92-533741
Synonyms:
(+)-(R,R)-trans-Tramadol
(+)-Tramadol
(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol
(+)-trans-Tramadol free ba
(1R,2R)-2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
(1R,2R)-2-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexanol
(1R,2R)-2-[(dimethylamino)methyl]-1-[3-(methyloxy)phenyl]cyclohexanol
27203-92-5
AC1L1Q6E
AC1Q59O2
AKOS005066335
Amanda
Amanda (TN)
BIDD:GT0075
C07153
CHEMBL1066
CID33741
Conzip
Crispin
D08623
DB00193
Durela
EINECS 248-319-6
HMS2090D10
Jsp005295
LS-57115
LS-57116
 
MLS000333190
MolPort-002-507-778
NCGC00159343-02
Ralivia
Ralivia ER
Ralivia Flashtab
Ralivia flashtab
Ryzolt
SMR000436547
STOCK4S-19075
Tradonal odis
Tramadol
Tramadol (INN)
Tramadol HCl
Tramadol HCl BP/EP
Tramadol Hydrochloride
Tramadol [INN:BAN]
Tramadol hydrochloride
Tramadolum
Tramadolum [INN-Latin]
Tramal
Tramodol Hcl
Tridural
UNII-39J1LGJ30J
Ultram
Ultram ER
Zydol
tramadol
11
DiatrizoateapprovedPhase 323117-96-42140
Synonyms:
2,4,6-Triiodo-3,5-diacetamidobenzoic acid
3,5-Bis(acetylamino)-2,4,6-triiodobenzoic acid
3,5-diacetamido-2,4,6-triiodobenzoic acid
Acide amidotrizoique
Acidum amidotrizoicum
Acidum diacetylaminotrijodbenzoicum
Amidotrizoate
Amidotrizoic Acid
Amidotrizoic acid (anhydrous)
Diatriazoate
Diatrizoate
Diatrizoate meglumine
 
Diatrizoate sodium
Diatrizoate sodium salt
Diatrizoesaure
Diatrizoic acid
Diatrizoic acid (anhydrous)
Diatrizoic acid sodium salt
Gastrografin
Md-gastroview
Methalamic acid
Sodium amidotrizoate
Sodium diatrizoate
Triombrin
Urografin acid
Urogranoic acid
12
Tenofovirapproved, investigationalPhase 3636147127-20-6464205
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-PMPA
147127-20-6
206184-49-8
AC-760
AC1LA9BO
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
GNA & Tenofovir
GS 1275
GS 1278
GS1278
HHA & Tenofovir
 
KS-5021
MolPort-003-850-411
NCGC00167535-01
PMPA
PMPA-(R)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
S1401_Selleck
TDF
TFV
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir Disoproxil Fumarate
Tenofovir disoproxil
Tenofovir disoproxil fumarate
UNII-99YXE507IL
Viread
Viread, Tenofovir
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
13
Emtricitabineapproved, investigationalPhase 3381143491-57-060877
Synonyms:
(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-.beta.-L-FTC
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(-)-FTC
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
143491-54-7
143491-57-0
145213-48-5
2',3',5-FTC
2',3'-Dideoxy-5-fluoro-3'-thiacytidine
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine
2'-Deoxy-5-fluoro-3'-thiacytidine
2-FTC
3'-Thia-2'.3'-dideoxy-5-fluorocytidine
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine
524W91
AC1L1U3I
AC1Q4KUB
BW 1592
 
BW 524W91
BW-524W91
BW524W91
C122114
C12599
C8H10FN3O3S
CHEBI:31536
CHEMBL885
CID60877
Coviracil
Coviracil(TM)
D01199
DB00879
DRG-0208
Emtricitabin
Emtricitabina
Emtricitabine
Emtricitabine (JAN/USAN/INN)
Emtricitabinum
Emtriva
Emtriva (TN)
Emtriva(TM)
FT-0080009
HMS2089I05
HSDB 7337
LS-135838
LS-173184
NCGC00164564-01
RCV
Racivir
SBB066061
TL8000958
UNII-G70B4ETF4S
ZINC03629271
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
dOTFC
emtricitabine
14Diatrizoate MegluminePhase 323
15UrovisionPhase 323
16
Tenofovir disoproxilPhase 3636201341-05-15481350
Synonyms:
201341-05-1
9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine
9-[(R)-2-[[Bis[[(isopropoxycarbonyl)oxy] methoxy]phosphinyl]methoxy]propyl]adenine
AC1NUKHG
Bis(POC)PMPA
Bis(isopropyloxymethylcarbonyl) 9-(2-phosphonomethoxypropyl)adenine
Bis(isopropyloxymethylcarbonyl)PMPA
CHEMBL1538
 
CID5481350
GS 4331-05 (*1:1 Fumarate salt*)
LS-187012
LS-187786
PMPA prodrug
ST51052782
TDF
Tenofovir disoproxil
Viread(TM) (*1:1 Fumarate salt*)
[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
17
LidocaineapprovedPhase 2991137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
18
Fentanylapproved, illicit, investigationalPhase 2649437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
19
Tadalafilapproved, investigationalPhase 2137171596-29-5110635
Synonyms:
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
ADCIRCA
Acdirca
Adcirca
C429886
CHEBI:41488
CHEMBL779
CID110635
CPD000466321
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
D02008
DB00820
FT-0080116
GF 196960
GF-196960
 
HMS2051N17
HSDB 7303
IC 351
IC-351
ICOS 351
Ic351
KS-1117
LS-186558
LS-187015
LS-187770
Lilly brand of tadalafil
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadanafil
UNII-742SXX0ICT
ZINC03993855
20
SolifenacinapprovedPhase 2103242478-37-1216457
Synonyms:
1-azabicyclo[2.2.2]oct-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
1-azabicyclo[2.2.2]octan-3-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo(2.2.2)oct-3-yl ester, (1S)-, butanedioate (1:1)
242478-37-1
242478-38-2
AC1L4BM3
AC1L50Q6
AC1L9FFR
AC1Q5VRD
AR-1L5425
Butanedioic acid, cmpd. with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
Butanedioic acid, compd with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1)
CHEMBL1200803
CHEMBL1734
CID154059
CID216457
CID443938
D08522
DB01591
 
LS-183550
MolPort-003-850-268
NCGC00168778-01
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylatemonosuccinate
Solifenacin
Solifenacin (INN)
Solifenacin [INN:BAN]
Solifenacin succinate
Solifenacin succinate [USAN]
UNII-A8910SQJ1U
UNII-KKA5DLD701
Vesicare
Vesikur
YM 905
YM-53705
YM-67905
YM-905
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate
butanedioic acid
solifenacin succinate
21
MirabegronapprovedPhase 276223673-61-8
Synonyms:
 
Myrbetriq
22Phosphodiesterase 5 InhibitorsPhase 2518
23MitomycinsPhase 1, Phase 2208
24
GemcitabineapprovedPhase 1180095058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine Hydrochloride
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
25
Docetaxelapproved, investigational, Approved May 1996Phase 11792114977-28-5148124, 9877265
Synonyms:
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate
(2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
01885_FLUKA
114977-28-5
4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate
AC-383
AC1L3WHJ
ANX-514
BIND-014
C11231
CHEBI:4672
CHEMBL92
CID148124
D07866
DB01248
Docefrez
Docetaxel
Docetaxel (INN)
Docetaxel anhydrous
Docetaxel, Trihydrate
EmDOC
 
HMS2089K08
InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5
MolPort-003-847-005
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel
N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol
N-debenzoyl-N-Boc-10-deacetyl taxol
NSC-628503
PSMA-targeted docetaxel nanoparticle
RP-56976
SDP-014
TXL
Taxotere
Taxotere (TN)
Taxotere(R)
XRP-6976L
docetaxel
docetaxel 114977-28-5
nchembio.188-comp8
nchembio.2007.34-comp7
nchembio.573-comp11
nchembio853-comp8
26
Iodine4597553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
27cadexomer iodine425
28
Tetracaine7394-24-65411
Synonyms:
136-47-0 (mono-hydrochloride)
2-(Dimethylamino)ethyl 4-(butylamino)benzoate
2-(Dimethylamino)ethyl p-(butylamino)benzoate
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]
2-dimethylaminoethyl 4-(butylamino)benzoate
4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester
4-14-00-01172 (Beilstein Handbook Reference)
4-[Butylamino]benzoic acid-2-[dimethylamino]ethyl ester
94-24-6
AB00053549
AC-3480
AC1L1KAQ
Amethocaine
Amethocaine (TN)
Anetain
BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER
BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE
BPBio1_000422
BRD-K45071273-003-05-8
BRN 2216051
BSPBio_000382
BSPBio_001944
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester
C07526
C15H24N2O2
CAS-136-47-0
CHEBI:9468
CHEMBL698
CID5411
Contralgin
D00551
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]
Dicain
Dicaine
Dikain
Dimethylaminoethyl p-butyl-aminobenzoate
DivK1c_000607
EINECS 202-316-6
Fissucain
I01-1872
IDI1_000607
InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H
Intercain
KBio1_000607
KBio2_001512
KBio2_004080
 
KBio2_006648
KBio3_001444
KBioGR_000781
KBioSS_001512
LS-36312
Laudocaine
Lopac-T-7508
Lopac0_001211
Medicaine
Medihaler-Tetracaine
Meethobalm
Metraspray
MolPort-001-783-476
Mucaesthin
NCGC00016049-01
NCGC00016049-02
NCGC00016049-04
NCGC00162367-01
NINDS_000607
Niphanoid
Pontocaine
Prestwick0_000571
Prestwick1_000571
Prestwick2_000571
Prestwick3_000571
Rexocaine
SBB058194
SPBio_001455
SPBio_002601
Spectrum2_001328
Spectrum3_000562
Spectrum4_000351
Spectrum5_001072
Spectrum_001032
T3812_SIAL
T7383_SIAL
T7383_SIGMA
Tetracaina
Tetracaina [INN-Spanish]
Tetracaine (USP/INN)
Tetracaine [USAN:INN]
Tetracainum
Tetracainum [INN-Latin]
Tetrakain
Tetrakain [Czech]
UNII-0619F35CGV
Uromucaesthin
p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester
p-Butylaminobenzoyl-2-dimethylaminoethanol
tetracaine

Interventional clinical trials:

(show top 50)    (show all 64)
idNameStatusNCT IDPhase
1Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet ObstructionCompletedNCT00147654Phase 4
2The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH PatientsCompletedNCT00696761Phase 4
3Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1CompletedNCT01661621Phase 4
4PVP Compared to TURP for the Treatment of Benign Hyperplasia of the ProstateCompletedNCT00527371Phase 4
5Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic BladderCompletedNCT01228370Phase 4
6Efficiency of Cold vs. Laser Internal Urethrotomy Treatment of Urethral StricturesRecruitingNCT01196572Phase 4
7An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic HyperplasiaRecruitingNCT00605319Phase 4
8Effects of Thoracic Epidural Administered Ropivacaine Versus Bupivacaine on Bladder FunctionRecruitingNCT02414373Phase 4
9Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized PatientsRecruitingNCT02006303Phase 4
10Treatment of Symptoms After Stent Placement for Urinary Tract ObstructionActive, not recruitingNCT01741454Phase 4
11Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral ColpopexyActive, not recruitingNCT00934999Phase 4
12BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic HyperplasiaActive, not recruitingNCT01533038Phase 4
13Memokath® 044TW Stent for Treatment of Urethral StrictureCompletedNCT00270504Phase 3
14Diagnosis of Urethral Stricture With Sono-urethrography vs Conventional Urethrography (SONO-URETHRA)RecruitingNCT01790776Phase 3
15Transobturator Subtrigonal Tape vs Transobturator Suburethral Tape for Stress Urinary IncontinenceRecruitingNCT02112591Phase 3
16DPNB for Prevention of CRDBRecruitingNCT01721031Phase 3
17The Safety and Effectiveness of UroLift: LIFT Pivotal StudyActive, not recruitingNCT01294150Phase 3
18Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal GraftNot yet recruitingNCT02551783Phase 3
19A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV InfectionNot yet recruitingNCT01697046Phase 3
20Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor UnderactivityCompletedNCT00441428Phase 2
21Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaCompletedNCT00252941Phase 1, Phase 2
22Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet ObstructionCompletedNCT00507455Phase 2
23A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)CompletedNCT00410514Phase 2
24Role of Uttarbasti in the Management of Mutra Marga Sankoch (Urethral Stricture)CompletedNCT00535717Phase 2
25A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization ProceduresCompletedNCT00142064Phase 2
26Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00386009Phase 2
27TRC105 in Adults With Advanced/Metastatic Urothelial CarcinomaCompletedNCT01328574Phase 2
28Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder ExstrophyRecruitingNCT02075216Phase 1, Phase 2
29Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate HyperplasiaActive, not recruitingNCT01436877Phase 1, Phase 2
30Effectiveness and Safety of Autologous Adipose-Derived Regenerative Cells for the Treatment of Urethral StricturesEnrolling by invitationNCT01889888Phase 1, Phase 2
31Effect of Mitomycin C on Urethral Stricture Recurrence After Internal UrethrotomyNot yet recruitingNCT00918528Phase 1, Phase 2
32Fetal Cystoscopy Versus Vesico-amniotic Shunting in Severe Lower Urinary Tract ObstructionsNot yet recruitingNCT01552824Phase 2
33Clinical Study for the Evaluation of the Safety and Initial Performance of the ClearRing System for the Treatment of Benign Prostatic HyperplasiaNot yet recruitingNCT02639442Phase 1, Phase 2
34Dorsal Penile Block for Post-Robotic Prostatectomy Foley DiscomfortWithdrawnNCT01565512Phase 1, Phase 2
35Two Devices for Reflex Voiding Following Spinal Cord InjuryCompletedNCT00662207Phase 1
36Fetal Cystoscopy for Lower Urinary Tract ObstructionRecruitingNCT02446184Phase 1
37Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial CancerRecruitingNCT02437370Phase 1
38Tiemann Mounted Urodynamic Catheter Technique for Difficult Bladder CatheterizationCompletedNCT02130843
39The Role of microRNAs in Organ Remodeling in Lower Urinary Tract DysfunctionCompletedNCT01482676
40The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) SubjectsCompletedNCT00710749
41The Effect of Caudal Block on the Postoperative Complications in Pediatric Patients After Hypospadias RepairCompletedNCT02164682
42Temperature Mapping of the Prostate With the Wallterm™ SystemCompletedNCT00662350
43Effects of Thoracic Epidural Anesthesia on Lower Urinary Tract FunctionCompletedNCT00790231
44Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled StudyCompletedNCT01220362
45Standardized Prenatal Clinical Care for LUTORecruitingNCT02315521
46Functional Outcome of Urethral Reconstructive SurgeryRecruitingNCT01982136
47Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff TestRecruitingNCT02031653
48Scandinavian Urethroplasty StudyRecruitingNCT02321670
49Dorsal Penile Nerve Block for Rigid Cystoscopy in MenRecruitingNCT02502487
50Ultrasound Guided Pudendal Block in Transurethral ProstatectomiesRecruitingNCT01501279

Search NIH Clinical Center for Urethral Obstruction


Cochrane evidence based reviews: Urethral Obstruction

Genetic Tests for Urethral Obstruction

About this section

Anatomical Context for Urethral Obstruction

About this section

MalaCards organs/tissues related to Urethral Obstruction:

33
Prostate, Kidney, Spinal cord, Smooth muscle, T cells, Colon, Skeletal muscle

Animal Models for Urethral Obstruction or affiliated genes

About this section

Publications for Urethral Obstruction

About this section

Articles related to Urethral Obstruction:

(show top 50)    (show all 284)
idTitleAuthorsYear
1
First experiences with the Spannera8c temporary prostatic stent for prostatic urethral obstruction. (23886821)
2013
2
Robotic-Assisted Urethrolysis for Urethral Obstruction After Retropubic Bladder Neck Suspension-A Case Series Report. (24074259)
2013
3
Preliminary Experience With Stenting for Management of Non-Urolith Urethral Obstruction in Eight Cats. (24350569)
2013
4
Large-conductance calcium-activated potassium channel activity, as determined by whole-cell patch clamp recording, is decreased in urinary bladder smooth muscle cells from male rats with partial urethral obstruction. (22520450)
2012
5
Laparoscopic-assisted urinary bladder marsupialization in a goat that developed recurrent urethral obstruction following perineal urethrostomy. (22947162)
2012
6
Use of fluoroscopically guided percutaneous antegrade urethral catheterization for the treatment of urethral obstruction in male cats: 9 cases (2000-2009). (22916857)
2012
7
Coccygeal epidural with local anesthetic for catheterization and pain management in the treatment of feline urethral obstruction. (21288294)
2011
8
Partial urethral obstruction: ATF3 and p-c-Jun are involved in the growth of the detrusor muscle and its motor innervation. (20969496)
2011
9
Delayed urethral obstruction after uterine torsion in a pregnant dog. (21896835)
2011
10
Beta3-adrenoceptors in the rat sacral spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction. (21661032)
2011
11
Fluoroscopic stent placement for the relief of malignant urethral obstruction in a cat. (21091459)
2010
12
Renal and cardiorespiratory effects of treatment with lactated Ringer's solution or physiologic saline (0.9% NaCl) solution in cats with experimentally induced urethral obstruction. (20594088)
2010
13
Retrospective study to characterize post-obstructive diuresis in cats with urethral obstruction. (20655493)
2010
14
Use of a balloon-expandable metallic stent to relieve malignant urethral obstruction in a cat. (19210243)
2009
15
Urethral obstruction due to lobular mesonephric hyperplasia of the vagina--a case report. (16758778)
2005
16
Evaluation of two techniques of partial urethral obstruction in the male rat model of bladder outlet obstruction. (16286152)
2005
17
Urodynamic follow-up of experimental urethral obstruction in individual guinea pigs. (11746551)
2001
18
Penile prolapse and urethral obstruction secondary to lymphosarcoma of the penis in a dog. (11563447)
2001
19
Functional urethral obstruction in 3 dogs: clinical and urethral pressure profile findings. (10668816)
2000
20
Changes in bladder contractility and compliance due to urethral obstruction: a longitudinal followup of guinea pigs. (10958732)
2000
21
Variations in strategy for the treatment of urethral obstruction after a pubovaginal sling procedure. (10893603)
2000
22
Urethral obstruction after primary exstrophy closure: what is the fate of the genitourinary tract? (9915471)
1999
23
Transvaginal urethrolysis for urethral obstruction after anti-incontinence surgery. (9507832)
1998
24
Recurrent urethral obstruction secondary to idiopathic renal hematuria in a puppy. (9826288)
1998
25
Congenital posterior urethral obstruction: the historical perspective. (9156879)
1997
26
Surgical management of a ruptured bladder secondary to a urethral obstruction in an alpaca. (9404609)
1997
27
Prenatal diagnosis and management of urethral obstruction. (9094819)
1997
28
Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. (9021786)
1997
29
Urethral obstruction in a dog: an unusual presentation of T-cell lymphoma. (9278118)
1997
30
Early urethral obstruction sequence: a lethal entity? (8838771)
1996
31
Urethral obstruction in a cat. (8870211)
1996
32
Urethral obstruction in a pup. (7782240)
1995
33
An unusual cause of urethral obstruction. (7974062)
1994
34
Effect of naftopidil on urethral obstruction in benign prostatic hyperplasia: assessment by urodynamic studies. (7517541)
1994
35
Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli. (8335372)
1993
36
Management of urethral obstruction with transvaginal urethrolysis. (8411421)
1993
37
Urethral obstruction sequence and lower limb deficiency: evidence for the vascular disruption hypothesis. (8355115)
1993
38
Acute urethral obstruction due to condylomata acuminata. (1923242)
1991
39
Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction. (1723990)
1991
40
Wallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patients. (1699698)
1990
41
Antenatal ultrasonic diagnosis of complete urethral obstruction in the fetus. (7446014)
1980
42
Feline cystitis, urethritis, urethral obstruction syndrome. Part III. Prophylaxis. (27715)
1978
43
Congenital urethral membranes causing urethral obstruction. (4810775)
1974
44
Approach to bladder neck and urethral obstruction in women. (4707075)
1973
45
An unusual cause of urethral obstruction in the dog. (5077658)
1972
46
Surgically induced partial urinary obstruction in the fetal lamb. II. Urethral obstruction. (5037967)
1972
47
Neo-natal ascites associated with urethral obstruction. (5626779)
1967
48
URETHRAL OBSTRUCTION: CORRECTION BY SUPRAPUBIC VESICOURETHRAL SUSPENSION. (14128371)
1964
49
Urethral obstruction in the female child. (13583054)
1958
50
Urethral obstruction in childhood; the use of urethrography in diagnosis. (13269355)
1955

Variations for Urethral Obstruction

About this section

Expression for genes affiliated with Urethral Obstruction

About this section
Search GEO for disease gene expression data for Urethral Obstruction.

Pathways for genes affiliated with Urethral Obstruction

About this section

Pathways related to Urethral Obstruction according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.5NRG1, SIRPA

GO Terms for genes affiliated with Urethral Obstruction

About this section

Biological processes related to Urethral Obstruction according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neurogenesisGO:00220089.3FAT4, NRG1

Sources for Urethral Obstruction

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet